COVID 19 infection as a cause of COPD exacerbation in a vaccinated
patient
- Sladjana Radosavljevic
, - Ilija Andrijevic,
- Jovan Matijasevic,
- Marija Vukoja
Sladjana Radosavljevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Corresponding Author:sladjaradosavljevic16@yahoo.com
Author ProfileIlija Andrijevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author ProfileJovan Matijasevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author ProfileMarija Vukoja
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author ProfileAbstract
According to a largest systematic review, COPD is a significant risk
factor for hospitalization, ICU admission and mortality in patients with
COVID-19. According to British Thoracic Society patients with severe
COPD are considered Clinically Extremely Vulnerable and should receive
COVID-19 vaccine. Pfizer's vaccine showed significant effectiveness
against COVID-19. In our case patient had severe form of COPD
exacerbation after vaccination, which required hospitalization and the
non-invasive ventilation but without intubation and radiology verified
pneumonia.
